RhumbLine Advisers’s PHARMACYCLICS INC PCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-52,193
Closed -$13.4M 3186
2015
Q1
$13.4M Buy
52,193
+2,978
+6% +$575K 0.04% 420
2014
Q4
$6.02M Sell
49,215
-58
-0.1% -$7.41K 0.02% 705
2014
Q3
$5.79M Sell
49,273
-3,786
-7% -$431K 0.02% 705
2014
Q2
$4.76M Buy
53,059
+3,865
+8% +$363K 0.01% 824
2014
Q1
$4.93M Sell
49,194
-2,647
-5% -$344K 0.01% 828
2013
Q4
$5.48M Sell
51,841
-6,697
-11% -$813K 0.02% 769
2013
Q3
$8.1M Sell
58,538
-7,592
-11% -$842K 0.03% 582
2013
Q2
$5.25M Buy
+66,130
New +$5.4M 0.02% 754

Other funds holding PCYC

RhumbLine Advisers's PCYC Position: Q2 2015 in Review

RhumbLine Advisers sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 52,193 shares — an estimated $13.4M sold.

RhumbLine Advisers first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $13.4M in Q1 2015. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

  • RhumbLine Advisers reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
  • RhumbLine Advisers sold 52,193 PHARMACYCLICS INC shares in Q2 2015, an estimated $13.4M.
  • RhumbLine Advisers first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
  • RhumbLine Advisers's PHARMACYCLICS INC position peaked at $13.4M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on RhumbLine Advisers's 13F filing for Q2 2015, filed 4 Aug 2015.